Jay L Tuttle - Eli Lilly and Company

基本信息

浏览量：6

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 46 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

AB0502 CELLULAR AND PROTEOMIC CHANGES FOLLOWING ADMINISTRATION OF PERESOLIMAB, IN A PHASE 2A TRIAL IN RHEUMATOID ARTHRITIS

Benschop R.,Tuttle J., Emery P., Preuss C., Daniels M., Chang C.Y., Yachi P., Nirula A.

Annals of the Rheumatic Diseases (2024): 1521

引用0浏览0引用

Supplementary Tables 1-3 from A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), As Monotherapy and in Combination with Erlotinib in Advanced Cancer

Lee S. Rosen,Jonathan W. Goldman,Alain P. Algazi,P. Kellie Turner,Brian Moser,Tianle Hu,Xuejing Aimee Wang,Jay Tuttle,Volker Wacheck,James E. Wooldridge,Michaela Banck

openalex（2023）

引用0浏览0引用

POS0307 A PHASE 2 TRIAL OF PERESOLIMAB FOR ADULTS WITH RHEUMATOID ARTHRITIS

J. Tuttle,E. Drescher,J.A. Simon-Campos, P. Emery, M. Greenwald,A. Kivitz, H. Rha, P. Yachi, C. Kiley, A. Nirula

Annals of the Rheumatic Diseases (2023): 397

引用0浏览0引用

A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis

J. Tuttle,E. Drescher,J. A. Simon-Campos,P. Emery,M. Greenwald,A. Kivitz, H. Rha, P. Yachi, C. Kiley,A. Nirula

ANNALS OF THE RHEUMATIC DISEASES（2023）

引用44浏览0WOS引用

Supplementary Figure 1B from A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), As Monotherapy and in Combination with Erlotinib in Advanced Cancer

Lee S. Rosen,Jonathan W. Goldman,Alain P. Algazi,P. Kellie Turner,Brian Moser,Tianle Hu,Xuejing Aimee Wang,Jay Tuttle,Volker Wacheck,James E. Wooldridge,Michaela Banck

openalex（2023）

引用0浏览0引用

Cellular and Proteomic Changes Following Administration of Peresolimab, in a Phase 2a Trial in Rheumatoid Arthritis

Robert J. Benschop,Jay Tuttle,Paul Emery, Christoph Preuss, Mark Daniels, Veavi Ching-Yun Chan, Pia Yachi,Ajay Nirula

ARTHRITIS & RHEUMATOLOGY (2023): 4298-4300

引用0浏览0引用

Mirikizumab Regulates Genes Involved in Ulcerative Colitis Disease Activity and Anti-TNF Resistance: Results from a Phase 2 Study

Boyd Steere,Jochen Schmitz,Nick Powell,Richard Higgs,Klaus Gottlieb,Yushi Liu,Bochao Jia,Jay L. Tuttle,William J. Sandborn,Bruce E. Sands,Geert D'Haens,Walter Reinisch,Venkatesh Krishnan

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY（2023）

引用6浏览0WOS引用

Changes in Health-Related Quality of Life and Associations with Improvements in Clinical Efficacy: a Phase 2 Study of Mirikizumab in Patients with Ulcerative Colitis

Marla C. Dubinsky,Vipul Jairath,Brian G. Feagan,April N. Naegeli,Jay Tuttle,Nathan Morris,Mingyang Shan,Vipin Arora,Trevor Lissoos,Noah Agada,Toshifumi Hibi,Bruce E. Sands

BMJ OPEN GASTROENTEROLOGYno. 1 (2023)

引用5浏览0WOS引用

The Anti–sars-Cov-2 Monoclonal Antibody Bamlanivimab Minimally Affects the Endogenous Immune Response to COVID-19 Vaccination

Robert J. Benschop,Jay L. Tuttle,Lin Zhang,Josh Poorbaugh,Nicole L. Kallewaard,Peter Vaillancourt,Melissa Crisp,Thi Ngoc Vy Trinh,Joshua J. Freitas,Stephanie Beasley,Montanea Daniels,Natalie Haustrup,Richard E. Higgs,Ajay Nirula,Myron S. Cohen,Mary Marovich

SCIENCE TRANSLATIONAL MEDICINE（2022）

引用22浏览0WOSSCIENCE引用

Innovative Clinical Trial Design and Delivery: a Phase 3 COVID-19 Post-Exposure Prophylaxis Study in Skilled Nursing and Assisted Living Facilities (BLAZE-2)

Knorr Jack,Tuttle Jay L.,Sabo Janelle A., East Dawn H.,Price Karen L.,Shen Lei

Trialsno. 1 (2021)

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn